Dr. David J. Cohen and Dr. C. Michael Gibson Discuss: PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk November 5, 2021 2021 | Cardiology | Slides | TCT | Video Tags: 2021, Cardiology, slides, TCT, video Loading… Taking too long? Reload document | Open in new tab Download Disclosures: TBD Article Navigation Dr. Nicolas Van Mieghem and Dr. Yaz Dabboul Discuss: SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk Dr. DJ Lakkireddy and Dr. C. Michael Gibson Discuss: AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion
Reload document 
Open in new tab